Skip to main content
. 2018 Nov 21;39(2):205–213. doi: 10.1007/s40261-018-0729-y

Table 4.

Incidence rate ratios for the interaction between tendon rupture and current systemic fluoroquinolone and oral corticosteroid exposure

Tendon rupture Exposed cases/total Exposed controls/total Adjusted IRR Adjusted p value
Any tendon rupture
Oral corticosteroid alone 287/4836 443/18,356 2.58 (2.19–3.03) < 0.001
Oral corticosteroid plus fluoroquinolone exposure 36/4836 20/18,356 6.88 (3.93–12.03) < 0.001
Achilles tendon rupture
Oral corticosteroid alone 148/1557 180/6007 4.59 (3.43–6.14) < 0.001
Oral corticosteroid plus fluoroquinolone exposure 37/1557 10/6007 19.36 (7.78–48.19) < 0.001

Adjusted for exact age, body mass index, Charlson co-morbidity score, hypothyroidism, hyperthyroidism, injectable corticosteroid therapy, smoking status, statin therapy and prior history of tendon rupture

IRR incidence rate ratio